Skip to main content
. 2009 Apr 20;11(4):461–477. doi: 10.1038/aja.2009.5

Figure 3.

Figure 3

Voiding parameters in symptomatic patients showing positive localizations of traditional uropathogens (TU) or unusual pathogens (UP) using the five-glass (black bars), four-glass (white bars), or two-glass (shaded bars) tests. Patients were subjected to one or two cycles of combination therapy with ciprofloxacin, azithromycin, alfuzosin, and S. repens. At microbiological eradication (time point T1), antibacterial agents were suspended and the remaining drugs were continued for a period of 6 months (T1–T2). The follow-up at the end of therapy was extended for 24 months, up to time point T6. (A): Time course of urine peak flow rate (Qmax). aP < 0.0001 vs. T0; bP = 0.046 vs. T1. Paired t-test. Intergroup differences at each time point (ANOVA): P > 0.1 (TU and UP together); P > 0.1 (TU only); P > 0.1 (UP only). (B): Time course of post-micturition percent bladder voided volume (% BVV). aP < 0.0001 vs. T0; bP = 0.005 vs. T0; cP = 0.01 vs. T0. Paired t-test. Intergroup differences at each time point (ANOVA): P > 0.1 (TU and UP together); P > 0.1 (TU only); P > 0.1 (UP only).